Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+ HSPCs for Sickle Cell Disease (SCD)Asif Alavi,Lakshmanan Krishnamurti,Mehrdad Abedi,Isobelle Galeon,David Reiner, Sharon E Smith,Lin Wang, Anne Ramezi,Pablo Rendo,Mark C. WaltersBlood(2021)引用 12|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要